Glycosphingolipid metabolic reprogramming drives neural differentiation

Autor: Alberto Luini, Riccardo Rizzo, Salvatore Fioriniello, Vittorio Maglione, Ilaria Granata, Kei Hori, Maurizio D'Esposito, Mario Rosario Guarracino, Serena Capasso, Mikio Hoshino, Domenico Russo, Ludger Johannes, Giovanni D'Angelo, Floriana Della Ragione, Francesco Scalabrì, Eiji Sugiyama, Lucia Sticco, Mitsutoshi Setou, Gian Carlo Bellenchi, Roberto De Gregorio
Rok vydání: 2017
Předmět:
0301 basic medicine
Epigenomics
sialyltransferase
nervous system development
bistability
neural differentiation
Regulator
Gene Expression
nerve cell differentiation
mental disease
ganglioside
glycosphingolipid
GM3 synthase
synthetase
unclassified drug
AUTS2 protein
human

haematoside synthetase
histone
protein
sialyltransferase
Article

AUTS2 gene
epigenetics
gene
gene expression
gene function
human
lipid metabolism
lipogenesis
metabolic regulation
neuropathology
nonhuman
priority journal
promoter region
regulatory mechanism
cell differentiation
drug effect
gene silencing
genetics
HeLa cell line
metabolism
nerve cell
nuclear reprogramming
physiology
Cell Differentiation

Cellular Reprogramming
Gangliosides
Gene Silencing
Glycosphingolipids
HeLa Cells
Histones
Humans
Neurodevelopmental Disorders
Neurogenesis
Neurons
Promoter Regions
Genetic

Proteins
Sialyltransferases
AUTS2
glycosphingolipids
chemistry.chemical_compound
Gene expression
News & Views
General Neuroscience
Cell Differentiation
Glycosphingolipid
Cell biology
lipids (amino acids
peptides
and proteins)

Reprogramming
Neural development
Biology
digestive system
Article
General Biochemistry
Genetics and Molecular Biology

Promoter Regions
03 medical and health sciences
Genetic
Epigenetics
Molecular Biology
General Immunology and Microbiology
Mechanism (biology)
AUTS2 protein
nutritional and metabolic diseases
carbohydrates (lipids)
Cytoskeletal Proteins
030104 developmental biology
chemistry
physiology
Function (biology)
Transcription Factors
Zdroj: EMBO journal
37 (2017): e97674. doi:10.15252/embj.201797674
info:cnr-pdr/source/autori:Russo, Domenico; Della Ragione, Floriana; Rizzo, Riccardo; Sugiyama, Eiji; Scalabrì, Francesco; Hori, Kei; Capasso, Serena; Sticco, Lucia; Fioriniello, Salvatore; De Gregorio, Roberto; Granata, Ilaria; Guarracino, Mario R.; Maglione, Vittorio; Johannes, Ludger; Bellenchi, Gian Carlo; Hoshino, Mikio; Setou, Mitsutoshi; D'Esposito, Maurizio; Luini, Alberto; D'Angelo, Giovanni/titolo:Glycosphingolipid metabolic reprogramming drives neural differentiation/doi:10.15252%2Fembj.201797674/rivista:EMBO journal (Print)/anno:2017/pagina_da:e97674/pagina_a:/intervallo_pagine:e97674/volume:37
ISSN: 1460-2075
DOI: 10.15252/embj.201797674
Popis: Neural development is accomplished by differentiation events leading to metabolic reprogramming. Glycosphingolipid metabolism is reprogrammed during neural development with a switch from globo‐ to ganglio‐series glycosphingolipid production. Failure to execute this glycosphingolipid switch leads to neurodevelopmental disorders in humans, indicating that glycosphingolipids are key players in this process. Nevertheless, both the molecular mechanisms that control the glycosphingolipid switch and its function in neurodevelopment are poorly understood. Here, we describe a self‐contained circuit that controls glycosphingolipid reprogramming and neural differentiation. We find that globo‐series glycosphingolipids repress the epigenetic regulator of neuronal gene expression AUTS2. AUTS2 in turn binds and activates the promoter of the first and rate‐limiting ganglioside‐producing enzyme GM3 synthase, thus fostering the synthesis of gangliosides. By this mechanism, the globo–AUTS2 axis controls glycosphingolipid reprogramming and neural gene expression during neural differentiation, which involves this circuit in neurodevelopment and its defects in neuropathology.
Databáze: OpenAIRE